Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma.
NAFLD
NASH
cancer metabolism
fibrosis
fructose
inflammation
malonyl-CoA
non-alcoholic fatty liver disease
non-alcoholic steatohepatitis
Journal
Cell metabolism
ISSN: 1932-7420
Titre abrégé: Cell Metab
Pays: United States
ID NLM: 101233170
Informations de publication
Date de publication:
08 01 2019
08 01 2019
Historique:
received:
05
04
2017
revised:
12
03
2018
accepted:
22
08
2018
pubmed:
25
9
2018
medline:
25
2
2020
entrez:
25
9
2018
Statut:
ppublish
Résumé
The incidence of hepatocellular carcinoma (HCC) is rapidly increasing due to the prevalence of obesity and non-alcoholic fatty liver disease, but the molecular triggers that initiate disease development are not fully understood. We demonstrate that mice with targeted loss-of-function point mutations within the AMP-activated protein kinase (AMPK) phosphorylation sites on acetyl-CoA carboxylase 1 (ACC1 Ser79Ala) and ACC2 (ACC2 Ser212Ala) have increased liver de novo lipogenesis (DNL) and liver lesions. The same mutation in ACC1 also increases DNL and proliferation in human liver cancer cells. Consistent with these findings, a novel, liver-specific ACC inhibitor (ND-654) that mimics the effects of ACC phosphorylation inhibits hepatic DNL and the development of HCC, improving survival of tumor-bearing rats when used alone and in combination with the multi-kinase inhibitor sorafenib. These studies highlight the importance of DNL and dysregulation of AMPK-mediated ACC phosphorylation in accelerating HCC and the potential of ACC inhibitors for treatment.
Identifiants
pubmed: 30244972
pii: S1550-4131(18)30521-7
doi: 10.1016/j.cmet.2018.08.020
pmc: PMC6643297
mid: NIHMS1507681
pii:
doi:
Substances chimiques
ACACA protein, human
EC 6.4.1.2
ACC1 protein, mouse
EC 6.4.1.2
Acacb protein, mouse
EC 6.4.1.2
Acetyl-CoA Carboxylase
EC 6.4.1.2
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
174-182.e5Subventions
Organisme : NCI NIH HHS
ID : K01 CA140861
Pays : United States
Organisme : European Research Council
ID : 671231
Pays : International
Organisme : CIHR
ID : 144625-1
Pays : Canada
Organisme : NCI NIH HHS
ID : T32 CA071345
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK099558
Pays : United States
Organisme : CIHR
ID : 125980-1
Pays : Canada
Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.
Références
J Biol Chem. 1978 Jun 25;253(12):4128-36
pubmed: 659409
Int J Cancer. 2016 Mar 15;138(6):1494-505
pubmed: 26481559
Annu Rev Nutr. 1996;16:523-57
pubmed: 8839937
Cancer Res. 2007 Dec 1;67(23):11141-6
pubmed: 18056438
Nat Med. 2013 Dec;19(12):1649-54
pubmed: 24185692
Science. 2011 Jan 28;331(6016):456-61
pubmed: 21205641
Cancer Res. 2008 Apr 1;68(7):2391-9
pubmed: 18381447
Mol Cancer Ther. 2012 Feb;11(2):503-13
pubmed: 22161861
Hepatology. 2014 Apr;59(4):1577-90
pubmed: 24677197
J Clin Invest. 2013 Jul;123(7):2764-72
pubmed: 23863634
Gastroenterology. 2016 Oct;151(4):733-746.e12
pubmed: 27342212
PLoS One. 2010 Nov 23;5(11):e15543
pubmed: 21124904
N Engl J Med. 2008 Jul 24;359(4):378-90
pubmed: 18650514
Histochem Cell Biol. 2011 Mar;135(3):305-15
pubmed: 21327394
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4320-5
pubmed: 22371574
Liver Int. 2016 Jan;36(1):108-18
pubmed: 26058462
Front Biosci (Schol Ed). 2010 Jan 01;2:515-26
pubmed: 20036965
Ann Oncol. 2013 Feb;24(2):543-53
pubmed: 23123507
Eur J Cancer. 2005 Jun;41(9):1316-22
pubmed: 15869874
Hepatology. 2013 May;57(5):1838-46
pubmed: 23299860
Eur J Med Res. 2013 Dec 09;18:54
pubmed: 24321741
Cancer Res. 2009 Sep 15;69(18):7385-92
pubmed: 19723656
Cell. 2010 Jan 22;140(2):197-208
pubmed: 20141834
Gastroenterology. 2011 Mar;140(3):1071-83
pubmed: 21147110
Hepat Oncol. 2015;2(4):371-379
pubmed: 26617981
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Cancer Cell. 2016 Dec 12;30(6):879-890
pubmed: 27960085
Hepatology. 2007 Sep;46(3):823-30
pubmed: 17680645
J Hepatol. 2012 Jun;56(6):1384-91
pubmed: 22326465
Nat Med. 2016 Oct;22(10):1108-1119
pubmed: 27643638
Nat Rev Dis Primers. 2016 Apr 14;2:16018
pubmed: 27158749
J Clin Invest. 2005 May;115(5):1343-51
pubmed: 15864352
Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):E1796-805
pubmed: 26976583
Cancer. 2016 Apr 15;122(8):1216-27
pubmed: 26914713